Titre:
  • Clinically significant lower elvitegravir exposure during the third trimester of pregnant patients living with human immunodeficiency virus: Data from the pharmacokinetics of antiretroviral agents in hiv-infected pregnant women (PANNA) network
Auteur:Bukkems, Vera; Necsoi, Coca Valentina; Tenorio, Carmen Hidalgo; Garcia, Coral; Rockstroh, Juergen; Schwarze-Zander, Caroline; Lambert, John Shearer; Burger, David; Konopnicki, Deborah; Colbers, Angela P H
Informations sur la publication:Clinical infectious diseases, 71, 10, page (E714-E717)
Statut de publication:Publié, 2020-11
Sujet CREF:Pathologie maladies infectieuses
Microbiologie et protistologie [bacteriol.,virolog.,mycolog.]
Microbiologie et protistologie [entomologie,phytoparasitolog.]
Microbiologie et protistologie [parasitologie hum. et anim.]
Mots-clés:Cobicistat
Elvitegravir
HIV
Pharmacokinetics
Pregnancy
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1093/cid/ciaa488
info:scp/85088375118
info:pmid/32330231